<VariationArchive VariationID="1361320" VariationName="NM_022356.4(P3H1):c.2154dup (p.Glu719fs)" VariationType="Duplication" Accession="VCV001361320" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1383692" VariationID="1361320">
      <GeneList>
        <Gene Symbol="P3H1" FullName="prolyl 3-hydroxylase 1" GeneID="64175" HGNC_ID="HGNC:19316" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42746374" stop="42767028" display_start="42746374" display_stop="42767028" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43212005" stop="43232754" display_start="43212005" display_stop="43232754" Strand="-" />
          </Location>
          <OMIM>610339</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_022356.4(P3H1):c.2154dup (p.Glu719fs)</Name>
      <CanonicalSPDI>NC_000001.11:42746753:GGGGGGG:GGGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p34.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42746753" stop="42746754" display_start="42746753" display_stop="42746754" variantLength="1" positionVCF="42746753" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43212431" stop="43212431" display_start="43212431" display_stop="43212431" variantLength="2" positionVCF="43212431" referenceAlleleVCF="A" alternateAlleleVCF="GG" />
      </Location>
      <ProteinChange>E719fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.43212431delinsGG" Assembly="GRCh37">
            <Expression>NC_000001.10:g.43212431delinsGG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.42746760dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.42746760dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008123.1" sequenceAccession="NG_008123" sequenceVersion="1" change="g.25331dup">
            <Expression>NG_008123.1:g.25331dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001146289.2" sequenceAccession="NM_001146289" sequenceVersion="2" change="c.*79dup">
            <Expression>NM_001146289.2:c.*79dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001243246.2" sequenceAccession="NM_001243246" sequenceVersion="2" change="c.*158dup">
            <Expression>NM_001243246.2:c.*158dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022356.4" sequenceAccession="NM_022356" sequenceVersion="4" change="c.2154dup" MANESelect="true">
            <Expression>NM_022356.4:c.2154dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_071751.3" sequenceAccession="NP_071751" sequenceVersion="3" change="p.Glu719fs">
            <Expression>NP_071751.3:p.Glu719fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_5t1" sequenceAccession="LRG_5t1">
            <Expression>LRG_5t1:c.2154dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_5" sequenceAccession="LRG_5">
            <Expression>LRG_5:g.25331dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="752671524" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022356.4(P3H1):c.2154dup (p.Glu719fs) AND Osteogenesis imperfecta type 8" Accession="RCV001907474" Version="6">
        <ClassifiedConditionList TraitSetID="334">
          <ClassifiedCondition DB="MedGen" ID="C1970458">Osteogenesis imperfecta type 8</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-08-04" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-04" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22615817</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27864101</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="334" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3681" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type 8</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+8/5463" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012581" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type VIII</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI8</ElementValue>
                <XRef Type="MIM" ID="610915" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">P3H1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10152" />
                <XRef ID="10152" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1970458" DB="MedGen" />
              <XRef ID="MONDO:0012581" DB="MONDO" />
              <XRef Type="MIM" ID="610915" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5003950" SubmissionDate="2022-08-03" DateLastUpdated="2022-08-08" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_022356_3_P3H1_c_2154dupC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002557115" DateUpdated="2022-08-08" DateCreated="2022-08-08" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22615817</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27864101</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with osteogenesis imperfecta, type VIII (MIM#610915). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0205 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with less than 1/3 of the protein sequence affected. (SP) 0252 - This variant is homozygous. (I) 0304 - Variant is present in gnomAD (v3) &lt;0.01 for a recessive condition (2 heterozygotes, 0 homozygotes). (SP) 0601 - Variant truncates the the well-established functional KDEL ER-retrieval motif. The KDEL motif is required to retain P3H1 protein in the endoplasmic reticulum where it is involved in the post-translational modification of collagen (UniProt, PMID: 22615817). (SP) 0704 - Another truncating variant comparable to the one identified in this case has limited previous evidence for pathogenicity. A truncating variant downstream of this variant has been reported in one unrelated individual with osteogenesis imperfecta (PMID: 27864101). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. This variant was reported compound heterozygous in an individual with osteogenesis imperfecta (PMID: 22615817). (SP) 0906 - Segregation evidence for this variant is inconclusive. The family reported by Takagi et al had a second pregnancy affected similarly to the proband, with the same variants (PMID: 22615817). (I) 1001 - This variant has strong functional evidence supporting abnormal protein function. In patient cells, Takagi et al found that although this mutant transcript was expressed there was a complete absence of intracellular protein, and observed an overmodification of collagen (PMID: 22615817). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="P3H1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_14816</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_022356.3:c.2154dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610915" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7818078" SubmissionDate="2023-12-17" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_022356.4:c.2154dup|OMIM:610915" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004177415" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="P3H1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_022356.4:c.2154dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610915" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14095410</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4142811" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="5771183|MedGen:C1970458" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002122435" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27864101</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22615817</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the P3H1 protein in which other variant(s) (p.Q722*) have been observed in individuals with P3H1-related conditions (PMID: 27864101). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1361320). This premature translational stop signal has been observed in individual(s) with osteogenesis imperfecta (PMID: 22615817). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Glu719Argfs*11) in the P3H1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 18 amino acid(s) of the P3H1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="P3H1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.43212424_43212425insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1970458" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4142811" TraitType="Disease" MappingType="XRef" MappingValue="C1970458" MappingRef="MedGen">
        <MedGen CUI="C1970458" Name="Osteogenesis imperfecta type 8" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5003950" TraitType="Disease" MappingType="XRef" MappingValue="610915" MappingRef="OMIM">
        <MedGen CUI="C1970458" Name="Osteogenesis imperfecta type 8" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7818078" TraitType="Disease" MappingType="XRef" MappingValue="610915" MappingRef="OMIM">
        <MedGen CUI="C1970458" Name="Osteogenesis imperfecta type 8" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

